Heinkel AG
Chinese Partner intends to join HEINKEL
Ad-hoc-announcement processed and transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Chinese Partner intends to join HEINKEL – Investment will significantly
strengthen the equity
Bietigheim-Bissingen, May 14, 2004
The longterm Chinese sales partner of HEINKEL AG, the Beijing Tianli Cryogenic
Process Equipment Co. Ltd. (TIANLI Technology) located in Beijing, intends to
join HEINKEL as major shareholder and to contribute with a significant amount to
the strengthening of the corporation’s equity. TIANLI Technology gave a
commitment to the corporation to subscribe for 1.443.250 new shares of the
HEINKEL AG at a share issue price of EURO 1,00 per share for the purposes of the
capital increase which shall be resolved in the or-dinary General Meeting on
May, 27, 2004 in Ludwigsburg.
However, among others the investment of the Chinese partner is subject to the
condition that the Federal Financial Supervisory Authority (Bundesanstalt für
Finanzdienstleistungsaufsicht – BaFin) approves the motion to release the
investor from the obligation to make an obligatory offer to all shareholders in
accordance with section 35 of the German Securities Acquisition and Takeover Act
(Wertpapiererwerbs- und Übernahmegesetz – WpÜG). The required preemptive rights
to subscribe the new shares will be exclusively transferred by the CIK
Vermögensverwaltungs GmbH & Co. KG, Stuttgart, without any payments.
Knowing this background the CIK Vermögensverwaltungs GmbH & Co. KG has filed a
counter-motion with regard to topic no. 7 of the agenda of the ordinary General
Meeting on May 27, 2004. The counter-motion of the CIK Vermögensverwaltungs GmbH
& Co. KG as well as the comment of the administration of the corporation are
available on the homepage of HEINKEL AG under http://www.heinkel.de.
The planned capital increase against contribution with the amount of altogether
EURO 2.5 Mio. should significantly strengthen the equity of the corporation. In
connection with the agreed Outside Financing and the significantly improved cost
position in the meantime, the whole corporation’s financing of HEINKEL AG is
now based on a solid foundation again. HEINKEL is further a long-term reliable
partner for our global customers in pharmaceuticals, fine-chemicals, chemicals
and biotechnology.
As a consequence of the implemented financial strengthening of the corporation,
the management can now push with full power the new strategic orientation of
HEINKEL, started in 2002 – in particular the expansion of the product range and
the further enlargement of the global sales and service activities.
A special focus of the future sales activities shall be in the region Asia – and
in particular in China – where we expect a further considerable growth in the
economy. The new designed cooperation between HEINKEL AG und TIANLI Technology,
which is the leading chinese manufacturer of process equipment and process
machines for the pharmaceutical industry, offers various future potentials for
the further strategic development of both companies. We are fully dedicated and
determined to use these great chances to obtain a sustainable growth and to come
back to the profit zone in a shortterm to the benefit of all our shareholders.
The CEO Tel: 07142-356-101
http://www.heinkel.de Fax: 07142-356-109
end of ad-hoc-announcement (c)DGAP 14.05.2004
——————————————————————————–
WKN: 605900; ISIN: DE0006059009; Index:
Listed: Amtlicher Markt in Frankfurt (General Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hamburg und Stuttgart
140838 Mai 04
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found